Main Article Content
Objectives: To compare effectiveness of Preeclampsia Care Map (PCaM) in preeclampsia management. Objective to compare the success rates of yielding the standard therapeutic level of magnesium, incidence of prescription error and deviated in management of preeclampsia before and after used preeclampsia care map.
Material and Method: This study was a Historical controls intervention trial. The study collected data from referral letters, medical records and PCaM form of pregnant women with diagnosis of preeclampsia with severe features and administered magnesium sulfate for prevention of convulsion, who delivered in Maharat Nakhon Ratchasima Hospital during December 2014 till July 2015 before used PCaM and December 2015 till July 2016 after used PCaM. Data were collected and analyzed using chi sqare.
Results: 141 patients were in era before using PCaM (before group) and 122 patients were in era after using PCaM (after group). No difference in the basic characteristics between the two groups was observed. After group compared to before group, the following outcomes were significant higher incidence in after group (RR (95% confidence interval)): the rate of achievement of therapeutic level of magnesium after delivery 1.1(1.0-1.3), incidence of proper maintenance dose of magnesium sulfate 1.2 (1.1-1.3), not delay adjusted dose of magnesium sulfate 1.4 (1.2-1.8) and proper dose for adjust magnesium sulfate 1.1(1.1- 1.1).
Conclusion: Preeclampsia Care Map (PCaM) had efficacy to increase the rate of achievement of therapeutic level of magnesium sulfate after delivery, incidence of proper maintenance dose of magnesium sulfate, not delay adjusted dose of magnesium sulfate and proper dose for adjust magnesium sulfate.
Key word: preeclampsia, care map, magnesium sulfate
2. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY, et al. Hypertensive disorders in pregnancy. Williams Obstetrics. 24th. ed. New York: McGraw-Hill Education; 2014:728.
3. Nhu Thi Nguyen Ngoc, Mario Merialdi, Hany Abdel-Aleem, Guillermo Carroli, Manorama Purwar, Nelly Zavaleta, et al. Causes of stillbirths and early neonatal deaths: data from 7993 pregnancies in six developing countries. Bull World Health Organ 2006;84(9):699-705.
4. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345(8963):1455-63.
5. Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, et al. Do women with preeclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo controlled trial. Lancet 2002;359(9321):1877-90.
6. Kitiyodom S. Eclampsia in Maharat Nakhon Ratchasima Hospital. Med J Srisaket Surin Buriram Hosp 2014; 29(3):129-38.
7. Boonyongchaisawat R, Kitiyodom S. Association between maternal BMI and sub-therapeutic serum magnesium level in severe pre-eclampsia in Maharat Nakhon Ratchasima Hospital. Thai J Obstet Gynaecol 2016;24:1-7.
8. Jaisamut P, Kitiyodom S. Effect of Maternal Body Mass Index on Serum Magnesium Level in Pregnant Women with Preeclampsia at Maharat Nakhon Ratchasima Hospital. Thai J Obstet Gynaecol 2016;25(3):159-66.
9. Kitiyodom S. Comparison of the Level of Magnesium during Maintenance between 2 Gram and 1 Gram per Hour Infusion in Overweight Mothers with Preeclampsia. J Med Assoc Thai 2016;99 Suppl 7:S133-7.
10. Kitiyodom S, Srithong P. Deviated management of preeclampsia with severe feature at Maharat Nakhon Ratchasima Hospital. Unpublished data.